136 related articles for article (PubMed ID: 29038345)
21. Identification of a novel circadian clock modulator controlling BMAL1 expression through a ROR/REV-ERB-response element-dependent mechanism.
Lee J; Lee S; Chung S; Park N; Son GH; An H; Jang J; Chang DJ; Suh YG; Kim K
Biochem Biophys Res Commun; 2016 Jan; 469(3):580-6. PubMed ID: 26692477
[TBL] [Abstract][Full Text] [Related]
22. Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin.
Wang F; Yang Y
Breast Cancer Res Treat; 2014 Aug; 147(1):203-10. PubMed ID: 25085754
[TBL] [Abstract][Full Text] [Related]
23. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).
Tsuchihashi K; Okazaki S; Ohmura M; Ishikawa M; Sampetrean O; Onishi N; Wakimoto H; Yoshikawa M; Seishima R; Iwasaki Y; Morikawa T; Abe S; Takao A; Shimizu M; Masuko T; Nagane M; Furnari FB; Akiyama T; Suematsu M; Baba E; Akashi K; Saya H; Nagano O
Cancer Res; 2016 May; 76(10):2954-63. PubMed ID: 26980765
[TBL] [Abstract][Full Text] [Related]
24. CLOCK and BMAL1 Regulate Muscle Insulin Sensitivity via SIRT1 in Male Mice.
Liu J; Zhou B; Yan M; Huang R; Wang Y; He Z; Yang Y; Dai C; Wang Y; Zhang F; Zhai Q
Endocrinology; 2016 Jun; 157(6):2259-69. PubMed ID: 27035655
[TBL] [Abstract][Full Text] [Related]
25. A circadian clock transcription model for the personalization of cancer chronotherapy.
Li XM; Mohammad-Djafari A; Dumitru M; Dulong S; Filipski E; Siffroi-Fernandez S; Mteyrek A; Scaglione F; Guettier C; Delaunay F; Lévi F
Cancer Res; 2013 Dec; 73(24):7176-88. PubMed ID: 24154875
[TBL] [Abstract][Full Text] [Related]
26. The epigenetic language of circadian clocks.
Sahar S; Sassone-Corsi P
Handb Exp Pharmacol; 2013; (217):29-44. PubMed ID: 23604474
[TBL] [Abstract][Full Text] [Related]
27. Calorie restriction regulates circadian clock gene expression through BMAL1 dependent and independent mechanisms.
Patel SA; Velingkaar N; Makwana K; Chaudhari A; Kondratov R
Sci Rep; 2016 May; 6():25970. PubMed ID: 27170536
[TBL] [Abstract][Full Text] [Related]
28. Identification of transcriptional regulatory elements required for the Mup2 expression in circadian clock mutant mice.
Cho YH; Kim D; Choi I; Bae K
Biochem Biophys Res Commun; 2011 Jul; 410(4):834-40. PubMed ID: 21703244
[TBL] [Abstract][Full Text] [Related]
29. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
30. Circadian Timekeeping in Anticancer Therapeutics: An Emerging Vista of Chronopharmacology Research.
Puppala A; Rankawat S; Ray S
Curr Drug Metab; 2021; 22(13):998-1008. PubMed ID: 34802402
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Circadian Clock in the Inferior Colliculus and Its Dysregulation by Noise Exposure.
Park JS; Cederroth CR; Basinou V; Meltser I; Lundkvist G; Canlon B
J Neurosci; 2016 May; 36(20):5509-19. PubMed ID: 27194331
[TBL] [Abstract][Full Text] [Related]
32. Structure-Activity-Relationship-Aided Design and Synthesis of xCT Antiporter Inhibitors.
Cirillo D; Sarowar S; Øyvind Enger P; Bjørsvik HR
ChemMedChem; 2021 Sep; 16(17):2650-2668. PubMed ID: 33847044
[TBL] [Abstract][Full Text] [Related]
33. The circadian clock and asthma.
Durrington HJ; Farrow SN; Loudon AS; Ray DW
Thorax; 2014 Jan; 69(1):90-2. PubMed ID: 23704227
[TBL] [Abstract][Full Text] [Related]
34. Chronotherapy and the molecular clock: Clinical implications in oncology.
Innominato PF; Lévi FA; Bjarnason GA
Adv Drug Deliv Rev; 2010 Jul; 62(9-10):979-1001. PubMed ID: 20600409
[TBL] [Abstract][Full Text] [Related]
35. Mitomycin C modulates the circadian oscillation of clock gene period 2 expression through attenuating the glucocorticoid signaling in mouse fibroblasts.
Kusunose N; Matsunaga N; Kimoto K; Akamine T; Hamamura K; Koyanagi S; Ohdo S; Kubota T
Biochem Biophys Res Commun; 2015 Nov; 467(1):157-63. PubMed ID: 26403971
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional oscillation of canonical clock genes in mouse peripheral tissues.
Yamamoto T; Nakahata Y; Soma H; Akashi M; Mamine T; Takumi T
BMC Mol Biol; 2004 Oct; 5():18. PubMed ID: 15473909
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
[TBL] [Abstract][Full Text] [Related]
38. Circadian Clock Regulates Bone Resorption in Mice.
Xu C; Ochi H; Fukuda T; Sato S; Sunamura S; Takarada T; Hinoi E; Okawa A; Takeda S
J Bone Miner Res; 2016 Jul; 31(7):1344-55. PubMed ID: 26841172
[TBL] [Abstract][Full Text] [Related]
39. Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock.
Lee Y; Lee J; Kwon I; Nakajima Y; Ohmiya Y; Son GH; Lee KH; Kim K
J Cell Sci; 2010 Oct; 123(Pt 20):3547-57. PubMed ID: 20930143
[TBL] [Abstract][Full Text] [Related]
40. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug.
Gout PW; Buckley AR; Simms CR; Bruchovsky N
Leukemia; 2001 Oct; 15(10):1633-40. PubMed ID: 11587223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
